Home > Quotes > XBI

SPDR Series Trust SPDR S&P Biotech ETF Stock Quote & Summary Data

(ETF)
XBI 
$110.03
*  
1.07
  negative  
0.98%
Get XBI Alerts
*Delayed - data as of May 17, 2013 


Community Rating:
 
 

Symbol List Views

ETF Details

CHARTS

ETF NEWS

FUNDAMENTALS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored

1 Year Target:
Today's High/Low:  / 
Share Volume:
90 Day Avg. Daily Volume This is the average share volume for the past 50 trading days, for NASDAQ stocks and 90 trading days for Non-NASDAQ stocks. This field allows you to compare today’s trading to the average daily volume. 224,207
Previous Close: $ 108.96
52 Week High /Low: $ 112.0899 / $ 76
Market cap “Market Capitalization” is a measure of the estimated value of the common equity securities of the company or their equivalent. It does not include securities convertible into the common equity securities. “Market Capitalization” is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). NASDAQ does not use this value to determine compliance with the listing requirements. 902,246,000
Annualized dividend $ 0.176
Ex Dividend Date Mar. 15, 2013
Dividend Payment Date Mar. 25, 2013
Current Yield 0.16 %

 Intraday Chart

5d | 1m | 6m | 12m | More Charting



Description:The SPDR S&P Biotech ETF seeks to replicate as closely as possible, before expenses, the performance of the S&P Biotechnology Select Industry Index (the "Index"). The Index represents the biotechnology sub-industry portion of the S&P Total Stock Market Index. The Index is one of nineteen (19) of the S&P Select Industry Indexes, each designed to measure the performance of a narrow sub-industry determined based on the Global Industry Classification Standards (GICS). The Index consists of the S&P Select Industry Indexes constituents belonging to the particular GICS sub-industry (e.g., biotechnology) that satisfy the following criteria: (i) rank within the 90th percentile of the float-adjusted market capitalization of the GICS sub-industry; (ii) are a U.S.-based company; and (iii) have a liquidity ratio greater than 60%. Under normal market conditions, the Fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the Index.

Underlying Index S&P Biotechnology Select Industry Index
Management Fee 0.35
Asset Class Equity
Leverage 1


News Headlines for XBI

A Journey To Add Biotech To The Portfolio
5/18/2013 2:38:00 AM - Seeking Alpha
Acorda Therapeutics, Inc. (ACOR): Today's Most Compelling Stock Buy
5/13/2013 12:15:25 PM - David Moenning
S&P Highlights Biotech ETFs
5/10/2013 7:39:21 AM - Benzinga
Pharmacyclics Inc. (PCYC): Today's Most Compelling Stock Buy
5/7/2013 1:53:41 PM - David Moenning
Polycyclics Inc. (PCYC): Today's Most Compelling Stock Pick
4/26/2013 3:20:21 PM - David Moenning
Top Holdings
ISIS Isis Pharmaceuticals 4.06%
NPSP Nps Pharmaceuticals 3.31%
ARNA Arena Pharmaceuticals 3.55%
SRPT Sarepta Therapeutics Inc 3.05%
INCY Incyte Corp. 3.5%
THRX Theravance 3.3%
SGEN Seattle Genetics 2.61%
SPPI Spectrum Pharmaceuticals 2.7%
PCYC Pharmacyclics 3.44%
CELG Celgene Corp. 3.27%
AMGN Amgen Inc. 2.61%
BIIB Biogen Idec Inc 2.61%
DVAX Dynavax Technologies Corp. 2.67%
REGN Regeneron Pharmaceuticals 2.57%
VRTX Vertex Pharmaceuticals Inc. 2.89%
KERX Keryx Biopharmaceuticals 2.55%
BMRN Biomarin Pharmaceutical Inc. 2.85%
DNDN Dendreon Corp. 2.83%
AFFY Affymax 2.9%
ALXN Alexion Pharmaceuticals 2.51%
ALKS Alkermes 2.62%
GILD Gilead Sciences 2.48%
IDIX Idenix Pharmaceuticals 2.86%
UTHR United Therapeutics Corp. 2.82%
ONXX Onyx Pharmaceuticals 2.45%